I just noticed a new addition to the Resverlogix events schedule. Sylwia Wasiak from Resverlogix is presenting on Monday September 11th at the 16th European Meeting on Complement in Human Disease (EMCHD) meeting in Copenhagen, Denmark in a 15 minute talk entitled: "BET inhibitor apabetalone (RVX-208) downregulates the complement cascade." 

And also as a reminder, Resverlogix will present at Rodman and Renshaw on Monday Sept 11 or Tuesday Sept 12 next week in New York (I'm not sure of which date). RVX isn't listed as a webcasting company as of right now, and when I asked Clayton he responded with "The Company will press release any scheduled webcasts in advance of the planned event." But maybe we will at least get a new slide deck to view? I'm not getting my hopes up though.

Have a great weekend everyone. 

BearDownAZ